Lurbinectedin in FET-Fused Tumors

Clinical trial NCT05918640 · RECRUITING

Trial details

NCT number: NCT05918640
Sponsor: Children's Hospital of Philadelphia
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ewing Sarcoma Desmoplastic Small Round Cell Tumor Pediatric Cancer Undifferentiated Sarcoma

Start date: 2023-07-27
Primary completion: 2027-07-30
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.